G01N 33/942
Serotonin, i.e. 5-hydroxy-tryptamine
Official title: {Serotonin, i.e. 5-hydroxy-tryptamine}
G01N33/942 (Serotonin, i.e. 5-hydroxy-tryptamine) appears on 67 US grants and 147 published applications in this corpus.
Search patents in G01N- Granted patents
- 67
- Published applications
- 147
- Assignees
- 73
- Inventors
- 228
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 3 |
| 2003 | 0 | 4 |
| 2004 | 0 | 1 |
| 2005 | 0 | 10 |
| 2006 | 0 | 6 |
| 2007 | 1 | 6 |
| 2008 | 2 | 2 |
| 2009 | 2 | 7 |
| 2010 | 1 | 5 |
| 2011 | 1 | 3 |
| 2012 | 2 | 8 |
| 2013 | 2 | 3 |
| 2014 | 4 | 5 |
| 2015 | 3 | 6 |
| 2016 | 2 | 8 |
| 2017 | 2 | 7 |
| 2018 | 3 | 6 |
| 2019 | 5 | 6 |
| 2020 | 4 | 3 |
| 2021 | 1 | 5 |
| 2022 | 6 | 11 |
| 2023 | 6 | 7 |
| 2024 | 7 | 11 |
| 2025 | 6 | 6 |
| 2026 | 1 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds and combinations thereof for treating neurological and psychiatric conditions10 Feb 2026US 12,544,345 B2Antecip Bioventures Ll LLC
- Compounds and combinations thereof for treating neurological and psychiatric conditions18 Nov 2025US 12,472,155 B2Antecip Bioventures II LLC
- Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders5 Aug 2025US 12,378,266 B2Mindset Pharma Inc.
- Compounds and combinations thereof for treating neurological and psychiatric conditions22 Jul 2025US 12,364,674 B2Antecip Bioventures II LLC
- Serotonin transporter gene and treatment of opioid-related disorders11 Feb 2025US 12,221,654 B2University of Virginia Patent Foundation
- Reagent pen testing device and method27 Aug 2026US 2026/0251666 A1Probitas LLC
- Combination of dextromethorphan and bupropion for treating neurological and psychiatric conditions with reduced neurotoxicity20 Aug 2026US 2026/0240835 A1Antecip Bioventures II LLC
- Ratiometric fluorescent sensor constructed based on g protein-coupled receptor and its construction method9 Jul 2026US 2026/0193314 A1Peking University
- Compounds and combinations thereof for treating neurological and psychiatric conditions28 May 2026US 2026/0144764 A1Antecip Bioventures II LLC
- Compounds and combinations thereof for treating neurological and psychiatric conditions14 May 2026US 2026/0130871 A1Antecip Bioventures II LLC
Most cited
By later US patents
- DNA encoding a human 5-HT.sub.1F receptor, vectors, and host cells50US 5,360,735 ASynaptic Pharmaceutical Corporation · 1994
- Treatment of depression in certain patient populations38US 11,730,706 B1Antecip Bioventures II LLC · 2023
- Compounds and combinations thereof for treating neurological and psychiatric conditions38US 11,752,144 B1Antecip Bioventures II LLC · 2023
- Compounds and combinations thereof for treating neurological and psychiatric conditions35US 11,839,612 B1Antecip Bioventures II LLC · 2023
- Treatment of depression in certain patient populations33US 11,883,373 B1Antecip Bioventures II LLC · 2024